Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Netherlands: Access to anti-retroviral drugs, male
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
22.9%
in 2024
Netherlands
89.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
18th
Netherlands rank
17th
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- Netherlands
How they compare
Netherlands currently reports 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 66.1%.
That makes Netherlands's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 24 years both countries report, Netherlands has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Netherlands ranks 17th of 19 groups.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 50.8% | 47.5% | Netherlands |
| 2010s | 10.3% | 76.8% | 66.5% | Netherlands |
| 2020s | 18.5% | 88.2% | 69.7% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Netherlands?
- Netherlands, at 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Netherlands?
- 66.1%, with Netherlands ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Netherlands?
- 24 years are reported by both, from 2000 to 2023.
- How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Netherlands rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Netherlands ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.